| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |